Published in J Natl Cancer Inst on November 01, 1974
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol (1986) 1.84
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45
Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18
Feline glucose-6-phosphate dehydrogenase cellular mosaicism. Application to the study of retrovirus-induced pure red cell aplasia. J Clin Invest (1985) 0.97
Feline preleukemia: an animal model of human disease. Yale J Biol Med (1979) 0.95
Identification of a putative receptor for subgroup A feline leukemia virus on feline T cells. J Virol (1992) 0.90
The diagnostic significance of a positive direct antiglobulin test in anemic cats. Can J Comp Med (1984) 0.86
Animal model: feline acute lymphoblastic leukemia and aplastic anemia. Am J Pathol (1977) 0.86
Recombination between feline exogenous and endogenous retroviral sequences generates tropism for cerebral endothelial cells. Am J Pathol (1994) 0.84
Hematopoietic target cells of anemogenic subgroup C versus nonanemogenic subgroup A feline leukemia virus. J Virol (1992) 0.82
Humoral immune response of asymptomatic cats naturally infected with feline leukemia virus. J Virol (1986) 0.80
In vitro activation of feline complement by feline leukemia virus. Infect Immun (1980) 0.80
Clinicopathologic responses in cats with feline leukemia virus-associated leukemia-lymphoma treated with staphylococcal protein A. Am J Pathol (1985) 0.80
Retroviral DNA-the silent winner: blood transfusion containing latent feline leukemia provirus causes infection and disease in naïve recipient cats. Retrovirology (2015) 0.79
The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group. Ann Intern Med (1990) 5.55
A new acute transforming feline retrovirus and relationship of its oncogene v-kit with the protein kinase gene family. Nature (1986) 4.90
Proposal for naming host cell-derived inserts in retrovirus genomes. J Virol (1981) 3.18
Molecular cloning of a feline leukemia virus that induces fatal immunodeficiency disease in cats. Science (1988) 2.86
Strong sequence conservation among horizontally transmissible, minimally pathogenic feline leukemia viruses. J Virol (1988) 2.62
Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS. Nature (1986) 2.52
Oral transmission and early lymphoid tropism of chronic wasting disease PrPres in mule deer fawns (Odocoileus hemionus). J Gen Virol (1999) 2.48
Horizontal transmission of feline leukaemia virus. Nature (1973) 2.34
A health status questionnaire using 30 items from the Medical Outcomes Study. Preliminary validation in persons with early HIV infection. Med Care (1991) 2.30
A transmissible feline fibrosarcoma of viral origin. Cancer Res (1971) 2.17
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine. J Virol (1996) 2.12
Transduction of endogenous envelope genes by feline leukaemia virus in vitro. Nature (1988) 1.94
Molecular analysis and pathogenesis of the feline aplastic anemia retrovirus, feline leukemia virus C-Sarma. J Virol (1986) 1.84
Viral genetic determinants of T-cell killing and immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1991) 1.83
Shared group-specific antigen of murine and feline leukemia viruses. Virology (1968) 1.78
Infection with human T-cell leukemia virus type I in patients with leukemia. N Engl J Med (1988) 1.78
A macrophage-monocyte cell line from a dog with malignant histiocytosis. In Vitro Cell Dev Biol (1988) 1.70
The frequency of occurrence of feline leukaemia virus subgroups in cats. Int J Cancer (1978) 1.66
Common cell surface antigen associated with mammalian C-type RNA viruses. Cell membrane-bound gs antigen. J Exp Med (1974) 1.61
Biology of feline leukemia virus in the natural environment. Cancer Res (1976) 1.59
Identification of three feline immunodeficiency virus (FIV) env gene subtypes and comparison of the FIV and human immunodeficiency virus type 1 evolutionary patterns. J Virol (1994) 1.59
Feline immunodeficiency virus: a neurotropic lentivirus. J Acquir Immune Defic Syndr (1990) 1.59
Immunosuppressive properties of a virion polypeptide, a 15,000-dalton protein, from feline leukemia virus. Cancer Res (1979) 1.56
Genetic diversity of feline immunodeficiency virus: dual infection, recombination, and distinct evolutionary rates among envelope sequence clades. J Virol (1997) 1.55
Identification of a CD4 homologue in the cat. Tissue Antigens (1990) 1.51
Replication in vitro and in vivo of an equine infectious anemia virus mutant deficient in dUTPase activity. J Virol (1995) 1.50
Experimentally induced feline chlamydial infection (feline pneumonitis). Am J Vet Res (1978) 1.48
Posttranslational modifications distinguish the envelope glycoprotein of the immunodeficiency disease-inducing feline leukemia virus retrovirus. J Virol (1989) 1.48
Pathogenic and host range determinants of the feline aplastic anemia retrovirus. Proc Natl Acad Sci U S A (1988) 1.45
PrP(CWD) in the myenteric plexus, vagosympathetic trunk and endocrine glands of deer with chronic wasting disease. J Gen Virol (2001) 1.45
The fine structure of the Yaba monkey tumor poxvirus. Cancer Res (1966) 1.39
Abrogation of lymphocyte blastogenesis by a feline leukaemia virus protein. Nature (1978) 1.39
Excretion of feline leukaemia virus by naturally infected pet cats. Nature (1977) 1.34
Partial dissociation of subgroup C phenotype and in vivo behaviour in feline leukaemia viruses with chimeric envelope genes. J Gen Virol (1992) 1.33
Characterisation of a tumour-specific antigen on the surface of feline lymphosarcoma cells. Nature (1978) 1.33
Pathogenesis of experimental feline leukemia virus infection. J Natl Cancer Inst (1979) 1.33
The roles of ATF3 in glucose homeostasis. A transgenic mouse model with liver dysfunction and defects in endocrine pancreas. J Biol Chem (2001) 1.31
Feline oncornavirus-associated cell-membrane antigen (FOCMA): distinction between FOCMA and the major virion glycoprotein. Proc Natl Acad Sci U S A (1977) 1.30
Natural feline leukemia virus infection and the immune response of cats of different ages. Cancer Res (1980) 1.28
Induction of accelerated feline immunodeficiency virus disease by acute-phase virus passage. J Virol (1995) 1.28
The Hardy-Zuckerman 2-FeSV, a new feline retrovirus with oncogene homology to Abelson-MuLV. Nature (1983) 1.26
Feline leukemia virus: occurrence of viral antigen in the tissues of cats with lymphosarcoma and other diseases. Science (1969) 1.26
Immunosurveillance of naturally occurring feline leukemia. Science (1975) 1.24
Longitudinal assessment of feline immunodeficiency virus kinetics in plasma by use of a quantitative competitive reverse transcriptase PCR. J Virol (1995) 1.23
RD-114 virus compared with feline and murine type-C viruses released from RD cells. Nat New Biol (1973) 1.23
Frequent perinatal transmission of feline immunodeficiency virus by chronically infected cats. J Virol (1996) 1.23
Common cell-surface antigen associated with murine and feline C-type RNA leukemia viruses. Proc Natl Acad Sci U S A (1973) 1.20
Vertical transmission of feline immunodeficiency virus. AIDS Res Hum Retroviruses (1995) 1.19
Immunologic reactivity of the cat: immunosuppression in experimental feline leukemia. J Natl Cancer Inst (1972) 1.19
Lessons from the cat: feline immunodeficiency virus as a tool to develop intervention strategies against human immunodeficiency virus type 1. AIDS Res Hum Retroviruses (1998) 1.19
Feline leukemia virus subgroup C phenotype evolves through distinct alterations near the N terminus of the envelope surface glycoprotein. Proc Natl Acad Sci U S A (1992) 1.18
Lymphocyte subset alterations and viral determinants of immunodeficiency disease induction by the feline leukemia virus FeLV-FAIDS. J Virol (1990) 1.18
Immunodiffusion analysis of Yaba poxvirus structural and associated antigens. J Virol (1970) 1.17
Evolution of feline leukemia virus variant genomes with insertions, deletions, and defective envelope genes in infected cats with tumors. J Virol (1994) 1.16
The in vitro soluble RNA methylase activity of SV40-induced hamster tumors. Cancer Res (1967) 1.15
Dose-related activity of stavudine in patients infected with human immunodeficiency virus. J Infect Dis (1995) 1.14
Early pathogenesis of disease caused by SIVsmmPBj14 molecular clone 1.9 in macaques. AIDS Res Hum Retroviruses (1993) 1.14
Feline immunodeficiency virus neurotropism: evidence that astrocytes and microglia are the primary target cells. Vet Immunol Immunopathol (1992) 1.14
Detection of the feline leukemia virus and other mammalian oncornaviruses by immunofluorescence. Bibl Haematol (1973) 1.13
Immune changes in HIV-1 infection: significant correlations and differences in serum markers and lymphoid phenotypic antigens. Clin Immunol Immunopathol (1992) 1.12
Bovine plasma thromboplastin antecedent (Factor XI) deficiency. J Lab Clin Med (1969) 1.12
Development of procoagulant (tissue thromboplastin) activity in cultured leukocytes. J Lab Clin Med (1972) 1.12
Hemorheologic abnormalities in patients with human immunodeficiency virus infection and ophthalmic microvasculopathy. Am J Ophthalmol (1990) 1.10
A feline leukaemia virus- and sarcoma virus-induced tumour-specific antigen. Nature (1977) 1.09
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med (1998) 1.09
Humoral immune responses of cats to feline leukemia virus: comparison of responses to the major structural protein p30 and to a virus-specific cell membrane antigen (FOCMA). J Natl Cancer Inst (1976) 1.08
Differences in clinical and convalescent-phase antibodies of Rhesus monkeys infected with monkey pox, tanapox, and Yaba poxviruses. Infect Immun (1973) 1.08
Serum-mediated leukemia cell destruction in AKR mice. J Exp Med (1973) 1.08
Growth of lion and puma lentiviruses in domestic cat cells and comparisons with FIV. Virology (1997) 1.07
Mucosal transmission of cell-associated and cell-free feline immunodeficiency virus. AIDS Res Hum Retroviruses (1997) 1.06
Experimentally induced feline calicivirus infection: clinical signs and lesions. J Am Vet Med Assoc (1975) 1.06
Demonstration of antibody in cat sera to feline oncornavirus by complement-fixation inhibition. J Natl Cancer Inst (1972) 1.06
Yaba tumor poxvirus synthesis in vitro. I. Cytopathological, histochemical, and immunofluorescent studies. J Bacteriol (1966) 1.05
Abrogation of resistance to feline oncornavirus disease by immunization with killed feline leukemia virus. Cancer Res (1977) 1.05
Characterization and significance of delayed processing of the feline leukemia virus FeLV-FAIDS envelope glycoprotein. J Virol (1990) 1.05
The Parodi-Irgens feline sarcoma virus and simian sarcoma virus have homologous oncogenes, but in different contexts of the viral genomes. J Virol (1983) 1.05
Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol Immunopathol (1991) 1.05
Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG. J Immunol (1991) 1.04
Yaba tumor poxvirus synthesis in vitro. 3. Growth kinetics. J Bacteriol (1966) 1.04
Modifications of the immunofluorescence assay for feline leukemia virus group-specific antigens. Am J Vet Res (1978) 1.03
Feline leukemia virus infection: age-related variation in response of cats to experimental infection. J Natl Cancer Inst (1976) 1.03
Application of the paired radioiodine-labeled antibody technique (PRILAT) to the detection of adenovirus 12 tumor (T) antigen. J Immunol (1970) 1.03
Immunodiffusion studies of feline leukemia and sarcoma. J Am Vet Med Assoc (1971) 1.03
Maternal-fetal feline immunodeficiency virus transmission: timing and tissue tropisms. J Infect Dis (1998) 1.02
Lesions produced by feline picornaviruses of different virulence in pathogen-free cats. Vet Pathol (1973) 1.02
Horizontal transmission of feline leukemia virus under natural conditions in a feline leukemia cluster household. Int J Cancer (1977) 1.02
Viruses and mammalian chromosomes. VI. Comparative karyologic and immunofluorescent studies on Syrian hamster and human amnion cells infected with human adenovirus type 12. Cancer Res (1966) 1.02
Sex-related resistance in hamsters to adenovirus-12 oncogenesis. Influence of thymectomy at three weeks of age. J Natl Cancer Inst (1965) 1.02
Yaba tumor poxvirus synthesis in vitro. II. Adsorption, inactivation, and assay studies. J Bacteriol (1966) 1.02
Purification of infectious feline leukemia virus from large volumes of tissue culture fluids. J Clin Microbiol (1977) 1.01
Reactivation of latent feline leukaemia virus infection. Nature (1982) 1.00
Models for AIDS pathogenesis: simian immunodeficiency virus, simian-human immunodeficiency virus and feline immunodeficiency virus infections. AIDS (1997) 1.00
Growth kinetics of Yaba tumor poxvirus after in vitro adaptation to cercopithecus kidney cells. J Virol (1970) 1.00
Structure and pathogenicity of individual variants within an immunodeficiency disease-inducing isolate of FeLV. Virology (1992) 1.00
Feline lymphomas: immunological and cytochemical characterization. Cancer Res (1989) 1.00